biosimilar approval

FDA Approves Accord BioPharma’s Denosumab Biosimilars, Expanding Access to Bone-Health Therapy

Durham, North Carolina, November 2025 Accord BioPharma has announced FDA approval of two denosumab biosimilars, OSVYRTI (denosumab-desu) and JUBEREQ...

By cGxPwire Editor
November 20, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

biosimilar approval

FDA Approves Accord BioPharma’s Denosumab Biosimilars, Expanding Access to Bone-Health Therapy